John W. Umstead V. - 10 May 2023 Form 4 Insider Report for G1 Therapeutics, Inc.

Role
Chief Financial Officer
Signature
/s /Sandi James, attorney-in-fact
Issuer symbol
N/A
Transactions as of
10 May 2023
Net transactions value
$0
Form type
4
Filing time
12 May 2023, 16:19:37 UTC
Previous filing
17 Mar 2023
Next filing
08 Jan 2024
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction GTHX Common Stock Award $0 +35,000 +59% $0.000000 93,886 10 May 2023 Direct F1, F2, F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Represents a restricted stock unit ("RSU") award that vests 50% on May 10, 2024 and 50% on May 10, 2025, subject to the Reporting Person's continued service through each applicable vesting date.
F2 Each RSU represents a contingent right to receive one share of Issuer common stock.
F3 Represents (i) 2,036 shares of common stock; (ii) 850 RSUs from award granted on January 4, 2021; (iii) 3,000 RSUs from award granted on January 3, 2022; (iv) 3,000 RSUs from award granted on January 3, 2023; (v) 50,000 RSUs from award granted on March 15, 2023; and (vi) 35,000 RSUs from award granted on May 10, 2023.